Hyperkinetic disorders can be difficult to diagnose, but correct identification is critical given the development of new treatments. This session focuses on Huntington’s chorea and tardive dyskinesia, two hyperkinetic disorders for which treatments are available. The session will cover the medications used to treat these disorders, including their mechanisms, efficacy, safety, and quality of life data based on clinical trials.
